Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,535Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Gowling Lafleur Henderson LLP

02 4Searchlight Pharma Inc.

03 2Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name : ENABLEX

Patent Number : 2230314

Filing Date : 1996-08-21

Strength per Unit : 7.5 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-08-21

Date Granted : 2003-06-24

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name : ENABLEX

Patent Number : 2230314

Filing Date : 1996-08-21

Strength per Unit : 15 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-08-21

Date Granted : 2003-06-24

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name : ENABLEX

Patent Number : 2469702

Filing Date : 2002-03-05

Strength per Unit : 7.5 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-03-05

Date Granted : 2010-07-06

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name : ENABLEX

Patent Number : 2480287

Filing Date : 2003-03-17

Strength per Unit : 7.5 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-03-17

Date Granted : 2011-05-31

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name : ENABLEX

Patent Number : 2469702

Filing Date : 2002-03-05

Strength per Unit : 15 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-03-05

Date Granted : 2010-07-06

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name : ENABLEX

Patent Number : 2480287

Filing Date : 2003-03-17

Strength per Unit : 15 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-03-17

Date Granted : 2011-05-31

blank

07

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name :

Patent Number : 2012295

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2010-03-15

Date Granted :

blank

08

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Darifenacin Hydrobromide

Brand Name :

Patent Number : 2012295

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2010-03-15

Date Granted :

blank